The GHJP is engaged in several policy and research projects that involve students, faculty, and domestic and international partners working on important global health justice issues in both academic and real-world settings.  
Click on each title or photo for more information.

GHJP is an interdisciplinary collaboration, committed to producing impactful and high quality scholarship that contributes to understanding and social change.  To facilitate this work, we aim to create a "Data for Health Justice Lab,” to foster collaborative, empirical research to address key issues in global health justice.

For the last two years, the GHJP has worked with its partner, the Sex Workers Project (SWP), of the Urban Justice Center NYC to understand the ways in which criminalization impacts the lives of people in the sex trade, with particular attention to the contradictory ways in which HIV/AIDS has become the main point of entry for legal engagement with sex workers. 

Ending an Epidemic: Overcoming the Barriers to an HCV-Free Future

Global Health Justice Partnership (GHJP) and Treatment Action Group (TAG) have filed a Freedom of Information Act (FOIA) lawsuit seeking open access to clinical trial data from the US Food and Drug Administration on the new treatments for hepatitis C, Sovaldi and Harvoni, manufactured by Gilead Sciences. GHJP and TAG are represented by the Media Freedom and Information Access Clinic (MFIA) at the Yale Law School.

This project addresses global efforts to extend treatment to millions with HCV, addressing obstacles to access and offers a comprehensive strategy for improving access to a new class of medicines for the disease, the directly acting antivirals (DAAs), in low- and middle-income countries and addressing these barriers.

This project addresses whether and how human rights norms and frameworks can be used to improve access to medicines (A2M) by reducing the barriers that intellectual property (IP) laws create. 

This project addresses the high cost of the new generation of treatments for hepatitis C in the United States, where the original prices for these drugs were listed in excess of $80,000 for a 12-week course. The GHJP is investigating policy options to decrease the prices of these medications by expediting access to generic equivalents of these compounds on the American market.

The Yale GHJP began working in 2014 to address the quarantines in Connecticut and collaborated with other public health and legal organizations to protest the actions of governors in New York and New Jersey who instituted similar policies. In 2015, the GHJP began a collaboration with the ACLU to develop an analysis of the public health, scientific and legal ramifications of the Ebola quarantine in the US.

This project analyzes how U.S. Congressional aid for the elimination of obstetric fistula in sub-Saharan Africa can promote effective, sustainable, and local interventions.

This project assesses and advocates for policy and clinical interventions in the co-epidemics of silicosis, tuberculosis, and HIV among mine workers and former mine workers in South Africa and labor-sending countries.

This project, in conjunction with the Transnational Development Clinic at Yale Law School, addresses the U.N.'s legal and moral responsibility to apologize and provide legal remedies for victims of Haiti's cholera epidemic.